摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

鸡矢藤苷 | 20547-45-9

中文名称
鸡矢藤苷
中文别名
鸡矢藤甙;鸡屎藤苷
英文名称
paederoside
英文别名
[(4S,7S,8S,11S)-2-oxo-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[5.3.1.04,11]undeca-1(10),5-dien-6-yl]methyl methylsulfanylformate
鸡矢藤苷化学式
CAS
20547-45-9
化学式
C18H22O11S
mdl
——
分子量
446.432
InChiKey
OJISWUQNQQWEND-FCVLBCLDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    122-123 °C
  • 沸点:
    737.3±70.0 °C(Predicted)
  • 密度:
    1.65±0.1 g/cm3(Predicted)
  • 溶解度:
    溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    30
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    187
  • 氢给体数:
    4
  • 氢受体数:
    12

安全信息

  • WGK Germany:
    3

制备方法与用途

鸡屎藤为茜草科鸡矢藤属多年生草质藤本植物鸡矢藤的全草及根,具有祛风除湿,消食化积,解毒消肿,活血止痛的功效。单独使用鸡矢藤甙(paederoside),具有较好的镇痛抗炎效果。鸡矢藤甙具有良好的外周镇痛效果和中枢神经镇痛效果,同时还具有良好的抗炎效果,因此,可单独或与药学上可接受的其它成分共同使用,制备止痛药物和抗炎药物。

鸡矢藤甙具有良好的外周镇痛效果和中枢神经镇痛效果,同时还具有良好的抗炎效果,因此,可单独或与药学上可接受的其它成分共同使用,制备止痛药物和/或抗炎药物。

一、一种鸡矢藤甙的制备方法,其特征在于包含以下步骤:

1)提取:取鸡屎藤药材粉碎,加入8-12倍量蒸馏水微波萃取2-3次,每次0.5-2h,过滤,得到提取液;

2)大孔树脂吸附:将上述提取液加入大孔树脂柱吸附,先用蒸馏水洗脱至下柱液无色,再用40-60%乙醇溶液洗脱,得到洗脱液;

3)聚酰胺分离:将上述洗脱液浓缩至无醇味,加入聚酰胺柱,依次用蒸馏水和30%乙醇洗脱,收集洗脱液;

4)重结晶:将上述洗脱液浓缩至小体积,放置结晶,滤出结晶,用乙醇回流溶解,滴加石油醚重结晶,滤出真空低温干燥即得鸡矢藤甙。

化学性质 
黄色粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于鸡屎藤Paederia scandense。
用途 
镇痛消炎。
用途 
用于含量测定/鉴定/药理实验等
药理药效:镇痛消炎

反应信息

  • 作为反应物:
    描述:
    鸡矢藤苷 在 barium(II) hydroxide 、 硫酸 、 mercury(II) cyanide 作用下, 反应 18.0h, 以3 mg的产率得到mercury(2+),methanethiolate
    参考文献:
    名称:
    Singh; Verma, Journal of the Indian Chemical Society, 2012, vol. 89, # 3, p. 429 - 431
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Hair dyeing
    申请人:TOKIWA KANPO PHARMACEUTICAL CO., LTD.
    公开号:EP0440494A2
    公开(公告)日:1991-08-07
    An iridoid glycoside, or an aglycone thereof, is used to dye hair, and for the manufacture of a cosmetic for dyeing hair.
    鸢尾甙或其苷元可用于染发和制造染发化妆品。
  • AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS
    申请人:N-Zyme BioTec GmbH
    公开号:EP3409766A1
    公开(公告)日:2018-12-05
    The present invention relates to a polypeptide having esterase activity selected from the group consisting of (a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 7; (b) a polypeptide that is at least 60 % identical to the amino acid sequence of SEQ ID NO: 7 and which is characterized by having an esterase activity; (c) a polypeptide encoded by a nucleic acid molecule which is at least 60 % identical to the nucleic acid sequence of SEQ ID NO: 5 or 6 wherein said polypeptide is characterized by having an esterase activity; (d) a polypeptide encoded by the nucleic acid molecule of SEQ ID NO: 5 or 6; and (e) a polypeptide encoded by the complementary sequence of a nucleic acid molecule that is able to hybridize with the nucleic acid molecule of SEQ ID NO: 5 or 6. Further, the present invention relates to a polypeptide having esterase activity selected from the group consisting of SEQ ID NO: 24 and 37 (as encoded by nuleic acid molecule of SEQ ID NO: 22 or 23 and SEQ ID NO: 35 and 36). The present invention also relates to a method for the production of oleacein, oleocanthal, or decarboxymethyl elenolic acid dialdehyde (DEDA) comprising the use of the esterase of the present invention. to an organism, preferably a plant cell, genetically engineered with a nucleic acid molecule encoding a polypeptide characterized by having an esterase activity or the vector of the present invention. The present invention also relates to a method for the production of oleacein, oleocanthal, and/or decarboxymethyl elenolic acid dialdehyde (DEDA) comprising the use of the esterase of the present invention.
    本发明涉及一种具有酯酶活性的多肽,该多肽选自由以下组成的组 (a) 包含 SEQ ID NO: 7 的氨基酸序列的多肽;(b) 与 SEQ ID NO: 7 的氨基酸序列至少 60% 相同的多肽,其特征在于具有酯酶活性;(c) 由核酸分子编码的多肽,该核酸分子与 SEQ ID NO: 5 或 6 的核酸序列至少 60% 相同,其中所述多肽的特征在于具有酯酶活性;(d) 由 SEQ ID NO: 5 或 6 的核酸分子编码的多肽;以及(e) 由 SEQ ID NO: 6 的核酸分子编码的多肽:5或6的核酸分子编码的多肽,其中所述多肽的特征在于具有酯酶活性;(d)由SEQ ID NO:5或6的核酸分子编码的多肽;以及(e)由能够与SEQ ID NO:5或6的核酸分子杂交的核酸分子的互补序列编码的多肽。此外,本发明涉及一种具有酯酶活性的多肽,该多肽选自 SEQ ID NO: 24 和 37(由 SEQ ID NO: 22 或 23 和 SEQ ID NO: 35 和 36 的核酸分子编码)组成的组。本发明还涉及一种生产油菜素、油菜醛或甲基醇酸二醛(DEDA)的方法,包括使用本发明的酯酶。本发明涉及一种生物体,最好是植物细胞,其基因工程中含有编码具有酯酶活性的多肽核酸分子或本发明的载体。本发明还涉及一种生产油菜素、油菜醛和/或甲基醇酸二醛(DEDA)的方法,包括使用本发明的酯酶
  • Iridoid glucosides from roots of Vietnamese Paederia scandens
    作者:D Quang
    DOI:10.1016/s0031-9422(02)00096-1
    日期:2002.7
    Four iridoid glucosides, three of which are dimeric were isolated from the methanol extract of roots of Vietnamese Paederia scandens (Lour) Merrill together with the five known glucosides, paederoside, asperuloside, paederosidic acid, asperulosidic acid and geniposide. Seven sulfur-containing iridoid glucosides were also isolated. The structures of the iridoid glucosides were determined by a combination of high-resolution NMR, MS, IR and UV spectra, and chemical reaction such as acetylation. (C) 2002 Elsevier Science Ltd. All rights reserved.
  • Iridoid Based Formulations
    申请人:West Brett Justin
    公开号:US20110217394A1
    公开(公告)日:2011-09-08
    Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids.
  • Acai and Iridoid Based Formulations
    申请人:West Brett Justin
    公开号:US20110206786A1
    公开(公告)日:2011-08-25
    Embodiments of the invention relate to fortified food and dietary supplement products, which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relate to the administration of products enhanced with Acai and iridoids.
查看更多